{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:39:06Z","timestamp":1778542746451,"version":"3.51.4"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-00553158"],"award-info":[{"award-number":["RS-2025-00553158"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-02232977"],"award-info":[{"award-number":["RS-2025-02232977"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003716","name":"Korea Basic Science Institute","doi-asserted-by":"publisher","award":["2023R1A6C101A009"],"award-info":[{"award-number":["2023R1A6C101A009"]}],"id":[{"id":"10.13039\/501100003716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1A6A1A06046728"],"award-info":[{"award-number":["2020R1A6A1A06046728"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002380","name":"Hanyang University","doi-asserted-by":"publisher","award":["HY202400000003857"],"award-info":[{"award-number":["HY202400000003857"]}],"id":[{"id":"10.13039\/501100002380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biotechadv.2025.108694","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T15:49:59Z","timestamp":1755877799000},"page":"108694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Engineering cyclized biomolecules for advanced diagnostic and therapeutic applications"],"prefix":"10.1016","volume":"84","author":[{"given":"Yeonju","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohyun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Pil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"32","key":"10.1016\/j.biotechadv.2025.108694_bb0005","doi-asserted-by":"crossref","first-page":"27026","DOI":"10.1074\/jbc.R111.305508","article-title":"Biological synthesis of circular polypeptides","volume":"287","author":"Aboye","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.biotechadv.2025.108694_bb0010","doi-asserted-by":"crossref","first-page":"7328","DOI":"10.1021\/acs.chemrev.8b00712","article-title":"Native chemical ligation and extended methods: mechanisms, catalysis, scope, and limitations","volume":"119","author":"Agouridas","year":"2019","journal-title":"Chem. Rev."},{"issue":"33","key":"10.1016\/j.biotechadv.2025.108694_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202109500","article-title":"A dual-targeting circular aptamer strategy enables the recognition of different leukemia cells with enhanced binding ability","volume":"61","author":"Ai","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"issue":"9","key":"10.1016\/j.biotechadv.2025.108694_bb0020","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.3390\/ijms25094622","article-title":"F peptides endowed with autophagy-inhibiting activity on cancer cell lines","volume":"25","author":"Albani","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.biotechadv.2025.108694_bb0025","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2302191120","article-title":"Circular RNA vaccine induces potent T cell responses","volume":"120","author":"Amaya","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biotechadv.2025.108694_bb0030","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/s41467-019-09678-w","article-title":"Spy&go purification of spytag-proteins using pseudo-spycatcher to access an oligomerization toolbox","volume":"10","author":"Anuar","year":"2019","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.biotechadv.2025.108694_bb0035","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jacc.2023.02.018","article-title":"Phase 2b randomized trial of the oral pcsk9 inhibitor mk-0616","volume":"81","author":"Ballantyne","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.biotechadv.2025.108694_bb0040","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.bmc.2017.09.002","article-title":"In-cell production of a genetically-encoded library based on the theta-defensin RTD-1 using a bacterial expression system","volume":"26","author":"Bi","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"8","key":"10.1016\/j.biotechadv.2025.108694_bb0045","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1096\/fj.11-182212","article-title":"Sortase a as a tool for high-yield histatin cyclization","volume":"25","author":"Bolscher","year":"2011","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.biotechadv.2025.108694_bb0050","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/bip.22306","article-title":"Recombinant expression of backbone-cyclized polypeptides","volume":"100","author":"Borra","year":"2013","journal-title":"Biopolymers"},{"key":"10.1016\/j.biotechadv.2025.108694_bb0055","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1038\/s41467-024-51610-4","article-title":"Proximity-driven site-specific cyclization of phage-displayed peptides","volume":"15","author":"Brown","year":"2024","journal-title":"Nat. Commun."},{"issue":"19\u201320","key":"10.1016\/j.biotechadv.2025.108694_bb0060","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.lfs.2010.03.015","article-title":"Linaclotide is a potent and selective guanylate cyclase c agonist that elicits pharmacological effects locally in the gastrointestinal tract","volume":"86","author":"Bryant","year":"2010","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.biotechadv.2025.108694_bb0065","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1021\/acs.molpharmaceut.1c00924","article-title":"Discovery of a cyclic cell-penetrating peptide with improved endosomal escape and cytosolic delivery efficiency","volume":"19","author":"Buyanova","year":"2022","journal-title":"Mol. Pharm."},{"issue":"43","key":"10.1016\/j.biotechadv.2025.108694_bb0070","doi-asserted-by":"crossref","first-page":"17057","DOI":"10.1021\/jacs.9b08085","article-title":"Selection of DNA-encoded libraries to protein targets within and on living cells","volume":"141","author":"Cai","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.biotechadv.2025.108694_bb0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/biomedicines7020031","article-title":"The potential of the cyclotide scaffold for drug development","volume":"7","author":"Camarero","year":"2019","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.biotechadv.2025.108694_bb0080","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1021\/acssynbio.4c00040","article-title":"Circular single-stranded DNA: discovery, biological effects, and applications","volume":"13","author":"Cao","year":"2024","journal-title":"ACS Syn. Biol."},{"issue":"7","key":"10.1016\/j.biotechadv.2025.108694_bb0085","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.70290","article-title":"Novel cyclized hexapeptide-9 outperforms retinol against skin aging: a randomized, double-blinded, active- and vehicle-controlled clinical trial","volume":"24","author":"Chang","year":"2025","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.biotechadv.2025.108694_bb0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/BCJ20180792","article-title":"Using backbone-cyclized cys-rich polypeptides as molecular scaffolds to target protein-protein interactions","volume":"476","author":"Chaudhuri","year":"2019","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.biotechadv.2025.108694_bb0095","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41587-022-01393-0","article-title":"Engineering circular RNA for enhanced protein production","volume":"41","author":"Chen","year":"2023","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.biotechadv.2025.108694_bb0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrd4503","article-title":"A holistic approach to targeting disease with polymeric nanoparticles","volume":"14","author":"Cheng","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biotechadv.2025.108694_bb0105","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bej.2015.10.022","article-title":"Phage based screening strategy for identifying enzyme substrates","volume":"105","author":"Cheok","year":"2016","journal-title":"Biochem. Eng. J."},{"issue":"1","key":"10.1016\/j.biotechadv.2025.108694_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4062\/biomolther.2019.082","article-title":"Recent trends in cyclic peptides as therapeutic agents and biochemical tools","volume":"28","author":"Choi","year":"2020","journal-title":"Biomol. Ther."},{"issue":"17","key":"10.1016\/j.biotechadv.2025.108694_bb0115","doi-asserted-by":"crossref","first-page":"9971","DOI":"10.1021\/acs.chemrev.8b00657","article-title":"Ligation technologies for the synthesis of cyclic peptides","volume":"119","author":"Chow","year":"2019","journal-title":"Chem. Rev."},{"issue":"4","key":"10.1016\/j.biotechadv.2025.108694_bb0120","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1021\/acs.jmedchem.0c01677","article-title":"Facile synthesis of cyclic peptide-phthalocyanine conjugates for epidermal growth factor receptor-targeted photodynamic therapy","volume":"64","author":"Chu","year":"2021","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.biotechadv.2025.108694_bb0125","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/bip.21372","article-title":"Native chemical ligation applied to the synthesis and bioengineering of circular peptides and proteins","volume":"94","author":"Clark","year":"2010","journal-title":"Biopolymers"},{"issue":"4","key":"10.1016\/j.biotechadv.2025.108694_bb0130","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1073\/pnas.052706399","article-title":"Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1","volume":"99","author":"Cole","year":"2002","journal-title":"Pro. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.biotechadv.2025.108694_bb0135","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/nn4057269","article-title":"Cell-penetrating peptides: design, synthesis, and applications","volume":"8","author":"Copolovici","year":"2014","journal-title":"ACS Nano"},{"issue":"5767","key":"10.1016\/j.biotechadv.2025.108694_bb0140","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1126\/science.1125248","article-title":"Chemistry - seamless proteins tie up their loose ends","volume":"311","author":"Craik","year":"2006","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.biotechadv.2025.108694_bb0145","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1021\/acschembio.4c00076","article-title":"Computational design of cyclic peptide inhibitors of a bacterial membrane lipoprotein peptidase","volume":"19","author":"Craven","year":"2024","journal-title":"ACS Chem. Biol."},{"issue":"6","key":"10.1016\/j.biotechadv.2025.108694_bb0150","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.drudis.2021.02.019","article-title":"Peptherdia: database and structure composition analysis of approved peptide therapeutics and diagnostics","volume":"26","author":"D'Aloisio","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biotechadv.2025.108694_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2023.106987","article-title":"Computational design of cyclic peptides to inhibit protein-peptide interactions","volume":"296","author":"Delaunay","year":"2023","journal-title":"Biophys. Chem."},{"issue":"4","key":"10.1016\/j.biotechadv.2025.108694_bb0160","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1039\/D0BM01755H","article-title":"Cell-penetrating peptides (cpps): an overview of applications for improving the potential of nanotherapeutics","volume":"9","author":"Desale","year":"2021","journal-title":"Biomater. Sci."},{"issue":"17","key":"10.1016\/j.biotechadv.2025.108694_bb0165","doi-asserted-by":"crossref","first-page":"10241","DOI":"10.1021\/acs.chemrev.9b00008","article-title":"Understanding cell penetration of cyclic peptides","volume":"119","author":"Dougherty","year":"2019","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.biotechadv.2025.108694_bb0170","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nrd2590","article-title":"The exploration of macrocycles for drug discovery\u2014an underexploited structural class","volume":"7","author":"Driggers","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.biotechadv.2025.108694_bb0175","doi-asserted-by":"crossref","first-page":"8384","DOI":"10.1021\/acs.jmedchem.1c00380","article-title":"Improving the gastrointestinal stability of linaclotide","volume":"64","author":"Emidio","year":"2021","journal-title":"J. Med. Chem."},{"issue":"29","key":"10.1016\/j.biotechadv.2025.108694_bb0180","doi-asserted-by":"crossref","first-page":"1705328","DOI":"10.1002\/adma.201705328","article-title":"Advances in biomaterials for drug delivery","volume":"30","author":"Fenton","year":"2018","journal-title":"Adv. Mater."},{"issue":"10","key":"10.1016\/j.biotechadv.2025.108694_bb0185","doi-asserted-by":"crossref","first-page":"18302","DOI":"10.3390\/s141018302","article-title":"Detection and characterization of cancer cells and pathogenic bacteria using aptamer-based nano-conjugates","volume":"14","author":"Gedi","year":"2014","journal-title":"Sensors"},{"issue":"17","key":"10.1016\/j.biotechadv.2025.108694_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300236","article-title":"Cell penetrating peptides: classification, mechanisms, methods of study, and applications","volume":"18","author":"Gori","year":"2023","journal-title":"ChemMedChem"},{"issue":"6","key":"10.1016\/j.biotechadv.2025.108694_bb0195","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1021\/acssensors.9b00489","article-title":"Detection and quantification of label-free infectious adenovirus using a switch-on cell-based fluorescent biosensor","volume":"4","author":"Guerreiro","year":"2019","journal-title":"ACS Sensors"},{"issue":"4","key":"10.1016\/j.biotechadv.2025.108694_bb0200","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","article-title":"Cell-penetrating peptides: from basic research to clinics","volume":"38","author":"Guidotti","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.biotechadv.2025.108694_bb0205","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.molmed.2007.08.002","article-title":"Tat transduction: the molecular mechanism and therapeutic prospects","volume":"13","author":"Gump","year":"2007","journal-title":"Trends Mol. Med."},{"issue":"18","key":"10.1016\/j.biotechadv.2025.108694_bb0210","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1039\/D1OB00411E","article-title":"Approaches for peptide and protein cyclisation","volume":"19","author":"Hayes","year":"2021","journal-title":"Org. Biomol. Chem."},{"issue":"8","key":"10.1016\/j.biotechadv.2025.108694_bb0215","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nchem.2811","article-title":"Cell-permeable nanobodies for targeted immunolabelling and antigen manipulation in living cells","volume":"9","author":"Herce","year":"2017","journal-title":"Nat. Chem."},{"issue":"20","key":"10.1016\/j.biotechadv.2025.108694_bb0220","doi-asserted-by":"crossref","first-page":"12584","DOI":"10.1021\/acs.chemrev.6b00825","article-title":"DNA origami: scaffolds for creating higher order structures","volume":"117","author":"Hong","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biotechadv.2025.108694_bb0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-0716-3914-6_9","article-title":"Cyclic peptide conjugate vaccines and physically mixed cyclic peptide vaccines for subcutaneous immunization","volume":"2821","author":"Huang","year":"2024","journal-title":"Methods Mol. Biol."},{"issue":"22","key":"10.1016\/j.biotechadv.2025.108694_bb0230","doi-asserted-by":"crossref","first-page":"6780","DOI":"10.1021\/jacs.8b03442","article-title":"Supramolecularly engineered circular bivalent aptamer for enhanced functional protein delivery","volume":"140","author":"Jiang","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.biotechadv.2025.108694_bb0235","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1039\/C8BM01340C","article-title":"Peptide ligand-mediated targeted drug delivery of nanomedicines","volume":"7","author":"Jiang","year":"2019","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.biotechadv.2025.108694_bb0240","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/CIRCULATIONAHA.122.063372","article-title":"Orally bioavailable macrocyclic peptide that inhibits binding of pcsk9 to the low density lipoprotein receptor","volume":"148","author":"Johns","year":"2023","journal-title":"Circulation"},{"issue":"7873","key":"10.1016\/j.biotechadv.2025.108694_bb0245","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with alphafold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biotechadv.2025.108694_bb0250","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tibs.2010.09.007","article-title":"Intramolecular isopeptide bonds: protein crosslinks built for stress?","volume":"36","author":"Kang","year":"2011","journal-title":"Trend. Biochem. Sci."},{"issue":"40","key":"10.1016\/j.biotechadv.2025.108694_bb0255","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1002\/anie.200700538","article-title":"Cyclic luciferase for real-time sensing of caspase-3 activities in living mammals","volume":"46","author":"Kanno","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"issue":"12","key":"10.1016\/j.biotechadv.2025.108694_bb0260","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.tibs.2015.10.004","article-title":"Mechanism matters: a taxonomy of cell penetrating peptides","volume":"40","author":"Kauffman","year":"2015","journal-title":"Trend. Biochem. Sci."},{"issue":"12","key":"10.1016\/j.biotechadv.2025.108694_bb0265","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nchembio.259","article-title":"Diverse backbone-cyclized peptides via codon reprogramming","volume":"5","author":"Kawakami","year":"2009","journal-title":"Nat. Chem. Biol."},{"issue":"52","key":"10.1016\/j.biotechadv.2025.108694_bb0270","doi-asserted-by":"crossref","first-page":"26523","DOI":"10.1073\/pnas.1909653116","article-title":"Approaching infinite affinity through engineering of peptide-protein interaction","volume":"116","author":"Keeble","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.biotechadv.2025.108694_bb0275","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1\u20132","key":"10.1016\/j.biotechadv.2025.108694_bb0280","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijpharm.2012.02.043","article-title":"Design of cyclic rkkh peptide-conjugated peg liposomes targeting the integrin \u03b1\u03b2 receptor","volume":"428","author":"Knudsen","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biotechadv.2025.108694_bb0285","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41467-023-36601-1","article-title":"Gene-encoding DNA origami for mammalian cell expression","volume":"14","author":"Kretzmann","year":"2023","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biotechadv.2025.108694_bb0290","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat. Rev. Genet."},{"issue":"9","key":"10.1016\/j.biotechadv.2025.108694_bb0295","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nchembio.193","article-title":"Rapid selection of cyclic peptides that reduce \u03b1-synuclein toxicity in yeast and animal models","volume":"5","author":"Kritzer","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biotechadv.2025.108694_bb0300","doi-asserted-by":"crossref","first-page":"1609165","DOI":"10.3389\/fimmu.2025.1609165","article-title":"Utilization of artificial circular rnas as mirna sponges and anti-pd-1 scfv expression platforms to suppress hepatocellular carcinoma progression","volume":"16","author":"Lai","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biotechadv.2025.108694_bb0305","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ncomms1459","article-title":"Backbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptides","volume":"2","author":"L\u00e4ttig-T\u00fcnnemann","year":"2011","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biotechadv.2025.108694_bb0310","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1021\/cr900361p","article-title":"Peptides and peptide hormones for molecular imaging and disease diagnosis","volume":"110","author":"Lee","year":"2010","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biotechadv.2025.108694_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126520","article-title":"Cyclized proteins with tags as permeable and stable cargos for delivery into cells and liposomes","volume":"252","author":"Lee","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"58","key":"10.1016\/j.biotechadv.2025.108694_bb0320","doi-asserted-by":"crossref","first-page":"14469","DOI":"10.1002\/chem.201702540","article-title":"In vivo evaluation of an engineered cyclotide as specific CXCR4 imaging reagent","volume":"23","author":"Lesniak","year":"2017","journal-title":"Chem. A Eur. J."},{"key":"10.1016\/j.biotechadv.2025.108694_bb0325","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/bs.abr.2015.08.006","article-title":"Chemical and biological production of cyclotides","volume":"76","author":"Li","year":"2015","journal-title":"Adv. Bot. Res."},{"issue":"8","key":"10.1016\/j.biotechadv.2025.108694_bb0330","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1021\/jacs.9b11490","article-title":"Enhanced in vivo blood\u2013brain barrier penetration by circular tau\u2013transferrin receptor bifunctional aptamer for tauopathy therapy","volume":"142","author":"Li","year":"2020","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.biotechadv.2025.108694_bb0335","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/cbic.202000003","article-title":"Circular nucleic acids: discovery, functions and applications","volume":"21","author":"Li","year":"2020","journal-title":"ChemBioChem"},{"issue":"12","key":"10.1016\/j.biotechadv.2025.108694_bb0340","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1039\/D2CC06176G","article-title":"Circular bivalent aptamers enhance the activation of the regenerative signaling pathway for repairing liver injury in vivo","volume":"59","author":"Liang","year":"2023","journal-title":"Chem. Commun."},{"issue":"6","key":"10.1016\/j.biotechadv.2025.108694_bb0345","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41587-019-0090-6","article-title":"Highly efficient expression of circular RNA aptamers in cells using autocatalytic transcripts","volume":"37","author":"Litke","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.biotechadv.2025.108694_bb0350","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","article-title":"Circular RNAs: characterization, cellular roles, and applications","volume":"185","author":"Liu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.biotechadv.2025.108694_bb0355","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.omtn.2018.09.010","article-title":"Synthetic circular RNA functions as a miR-21 sponge to suppress gastric carcinoma cell proliferation","volume":"13","author":"Liu","year":"2018","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.biotechadv.2025.108694_bb0360","article-title":"Recent advances in aptamer-based therapeutic strategies for targeting cancer stem cells","volume":"19","author":"Liu","year":"2023","journal-title":"Mat. Today Bio"},{"issue":"3","key":"10.1016\/j.biotechadv.2025.108694_bb0365","doi-asserted-by":"crossref","first-page":"bbae190","DOI":"10.1093\/bib\/bbae190","article-title":"Cyclicpepedia: a knowledge base of natural and synthetic cyclic peptides","volume":"25","author":"Liu","year":"2024","journal-title":"Brief. Bioinform."},{"issue":"1","key":"10.1016\/j.biotechadv.2025.108694_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/psc.366","article-title":"Peptides as drugs: is there a market?","volume":"8","author":"Loffet","year":"2002","journal-title":"J. Pept. Sci."},{"issue":"33","key":"10.1016\/j.biotechadv.2025.108694_bb0375","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1039\/D3TB01008B","article-title":"Design and fabrication of intracellular therapeutic cargo delivery systems based on nanomaterials: current status and future perspectives","volume":"11","author":"Ma","year":"2023","journal-title":"J. Mater. Chem. B"},{"issue":"9","key":"10.1016\/j.biotechadv.2025.108694_bb0380","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1021\/ja039915e","article-title":"Sortase-mediated protein ligation: a new method for protein engineering","volume":"126","author":"Mao","year":"2004","journal-title":"J. Am. Chem. Soc."},{"issue":"23","key":"10.1016\/j.biotechadv.2025.108694_bb0385","doi-asserted-by":"crossref","first-page":"12879","DOI":"10.3390\/ijms222312879","article-title":"Cyclic nucleotide (cnmp) analogues: past, present and future","volume":"22","author":"Maronde","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biotechadv.2025.108694_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116488","article-title":"Cyclic peptides: a powerful instrument for advancing biomedical nanotechnologies and drug development","volume":"252","author":"Martian","year":"2025","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"5428","key":"10.1016\/j.biotechadv.2025.108694_bb0395","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.285.5428.760","article-title":"Sortase, an enzyme that anchors surface proteins to the cell wall","volume":"285","author":"Mazmanian","year":"1999","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.biotechadv.2025.108694_bb0400","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41589-023-01496-y","article-title":"De novo development of small cyclic peptides that are orally bioavailable","volume":"20","author":"Merz","year":"2024","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.biotechadv.2025.108694_bb0405","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.biotechadv.2025.108694_bb0410","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrd.2018.125","article-title":"Constrained peptides' time to shine?","volume":"17","author":"Morrison","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.biotechadv.2025.108694_bb0415","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1039\/D3CB00015J","article-title":"Resistance is futile: targeting multidrug-resistant bacteria with cys-rich cyclic polypeptides","volume":"4","author":"Mourenza","year":"2023","journal-title":"RSC Chem. Biol."},{"issue":"12","key":"10.1016\/j.biotechadv.2025.108694_bb0420","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1073\/pnas.95.12.6705","article-title":"Expressed protein ligation: a general method for protein engineering","volume":"95","author":"Muir","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.biotechadv.2025.108694_bb0425","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1021\/acs.joc.9b02490","article-title":"In situ cyclization of proteins (INCYPRO): cross-link derivatization modulates protein stability","volume":"85","author":"Neubacher","year":"2020","journal-title":"J. Org. Chem."},{"issue":"5","key":"10.1016\/j.biotechadv.2025.108694_bb0430","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/17460441.2018.1445085","article-title":"Bioactive cyclic molecules and drug design","volume":"13","author":"Newman","year":"2018","journal-title":"Expert Opin. Drug Discovery"},{"issue":"6","key":"10.1016\/j.biotechadv.2025.108694_bb0435","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/anie.201410006","article-title":"Covalent attachment of cyclic tat peptides to gfp results in protein delivery into live cells with immediate bioavailability","volume":"54","author":"Nischan","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biotechadv.2025.108694_bb0440","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ymeth.2021.02.020","article-title":"The design and synthesis of circular RNAs","volume":"196","author":"Obi","year":"2021","journal-title":"Methods"},{"issue":"12","key":"10.1016\/j.biotechadv.2025.108694_bb0445","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.1039\/D3RA01358H","article-title":"Each side chain of cyclosporin a is not essential for high passive permeability across lipid bilayers","volume":"13","author":"Ono","year":"2023","journal-title":"RSC Adv."},{"issue":"12","key":"10.1016\/j.biotechadv.2025.108694_bb0450","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.bbamem.2010.02.004","article-title":"Delivering cargoes into cancer cells using DNA aptamers targeting internalized surface portals","volume":"1798","author":"Orava","year":"2010","journal-title":"Biochim. Biophys. Acta-Biomembr."},{"issue":"35","key":"10.1016\/j.biotechadv.2025.108694_bb0455","doi-asserted-by":"crossref","first-page":"9648","DOI":"10.1039\/D0SC02279A","article-title":"A bispecific circular aptamer tethering a built-in universal molecular tag for functional protein delivery","volume":"11","author":"Pan","year":"2020","journal-title":"Chem. Sci."},{"issue":"8","key":"10.1016\/j.biotechadv.2025.108694_bb0460","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00044-024-03269-1","article-title":"Peptide-based therapeutics: challenges and solutions","volume":"33","author":"Pereira","year":"2024","journal-title":"Med. Chem. Res."},{"issue":"1\u20132","key":"10.1016\/j.biotechadv.2025.108694_bb0465","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(97)00062-8","article-title":"Peptide hormones: review of current and emerging uses by nasal delivery","volume":"29","author":"Pontiroli","year":"1998","journal-title":"Adv. Drug Del. Rev."},{"issue":"8","key":"10.1016\/j.biotechadv.2025.108694_bb0470","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1073\/pnas.1016863108","article-title":"Sortase-catalyzed transformations that improve the properties of cytokines","volume":"108","author":"Popp","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.biotechadv.2025.108694_bb0475","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1021\/cb3005275","article-title":"Efficient delivery of cyclic peptides into mammalian cells with short sequence motifs","volume":"8","author":"Qian","year":"2013","journal-title":"ACS Chem. Biol."},{"issue":"18","key":"10.1016\/j.biotechadv.2025.108694_bb0480","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1021\/acs.biochem.6b00226","article-title":"Discovery and mechanism of highly efficient cyclic cell-penetrating peptides","volume":"55","author":"Qian","year":"2016","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.biotechadv.2025.108694_bb0485","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.cell.2022.03.044","article-title":"Circular RNA vaccines against sars-cov-2 and emerging variants","volume":"185","author":"Qu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.biotechadv.2025.108694_bb0490","article-title":"Targeted delivery of doxorubicin to tumor cells using engineered circular bivalent aptamer","volume":"75","author":"Rahimi","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biotechadv.2025.108694_bb0495","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nature04586","article-title":"Folding DNA to create nanoscale shapes and patterns","volume":"440","author":"Rothemund","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biotechadv.2025.108694_bb0500","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3762\/bjnano.11.10","article-title":"Internalization mechanisms of cell-penetrating peptides","volume":"11","author":"Ruseska","year":"2020","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.biotechadv.2025.108694_bb0505","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2013.10.003","article-title":"RNAi-mediated gene knockdown and anti-angiogenic therapy of rccs using a cyclic RGD-modified liposomal-siRNA system","volume":"173","author":"Sakurai","year":"2014","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.biotechadv.2025.108694_bb0510","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.addr.2009.07.003","article-title":"\"splicing up\" drug discovery. Cell-based expression and screening of genetically-encoded libraries of backbone-cyclized polypeptides","volume":"61","author":"Sancheti","year":"2009","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.biotechadv.2025.108694_bb0515","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3389\/fchem.2020.573259","article-title":"Rapid design of potential cyclic peptide binders targeting protein-protein interfaces","volume":"8","author":"Santini","year":"2020","journal-title":"Front. Chem."},{"issue":"3","key":"10.1016\/j.biotechadv.2025.108694_bb0520","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1515\/ejnm-2013-0005","article-title":"Therapeutic delivery using cell-penetrating peptides","volume":"5","author":"Sawant","year":"2013","journal-title":"Eur. J. Nanomed."},{"issue":"1","key":"10.1016\/j.biotechadv.2025.108694_bb0525","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1186\/s13063-021-05588-9","article-title":"Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate-to-severe ARDS-a randomized, placebo-controlled, double-blind trial","volume":"22","author":"Schmid","year":"2021","journal-title":"Trials"},{"issue":"24","key":"10.1016\/j.biotechadv.2025.108694_bb0530","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1002\/anie.201402519","article-title":"Spytag\/spycatcher cyclization confers resilience to boiling on a mesophilic enzyme","volume":"53","author":"Schoene","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"issue":"24","key":"10.1016\/j.biotechadv.2025.108694_bb0535","doi-asserted-by":"crossref","first-page":"13638","DOI":"10.1073\/pnas.96.24.13638","article-title":"Production of cyclic peptides and proteins","volume":"96","author":"Scott","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.biotechadv.2025.108694_bb0540","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1074-5521(01)00052-7","article-title":"Structural requirements for the biosynthesis of backbone cyclic peptide libraries","volume":"8","author":"Scott","year":"2001","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.biotechadv.2025.108694_bb0545","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7150\/thno.66466","article-title":"Single-stranded circular DNA theranostics","volume":"12","author":"Shen","year":"2022","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.biotechadv.2025.108694_bb0550","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1021\/acsomega.1c00532","article-title":"Genetic fusion of transacting activator of transcription peptide to cyclized green fluorescence protein improves stability, intracellular delivery, and tumor retention","volume":"6","author":"Shi","year":"2021","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.biotechadv.2025.108694_bb0555","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/mp3004034","article-title":"Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs","volume":"10","author":"Shirazi","year":"2013","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.biotechadv.2025.108694_bb0560","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3390\/ph14111064","article-title":"Cyclic peptide-gadolinium nanocomplexes as siRNA delivery tools","volume":"14","author":"Shirazi","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.biotechadv.2025.108694_bb0565","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-virology-101416-041953","article-title":"Viruses with circular single-stranded DNA genomes are everywhere!","volume":"4","author":"Shulman","year":"2017","journal-title":"Annu. Rev. Virol."},{"issue":"9","key":"10.1016\/j.biotechadv.2025.108694_bb0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162318","article-title":"Spytag\/spycatcher cyclization enhances the thermostability of firefly luciferase","volume":"11","author":"Si","year":"2016","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.biotechadv.2025.108694_bb0575","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1021\/acscentsci.0c00087","article-title":"Genetically encoded cyclic peptide phage display libraries","volume":"6","author":"Simonetti","year":"2020","journal-title":"ACS Central Sci."},{"issue":"2","key":"10.1016\/j.biotechadv.2025.108694_bb0580","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41570-019-0159-2","article-title":"Methods for generating and screening libraries of genetically encoded cyclic peptides in drug discovery","volume":"4","author":"Sohrabi","year":"2020","journal-title":"Nat. Rev. Chem."},{"issue":"9","key":"10.1016\/j.biotechadv.2025.108694_bb0585","doi-asserted-by":"crossref","first-page":"13954","DOI":"10.1021\/acsomega.9b01697","article-title":"Antimir-155 cyclic peptide-PNA conjugate: synthesis, cellular uptake, and biological activity","volume":"4","author":"Soudah","year":"2019","journal-title":"ACS Omega"},{"issue":"19","key":"10.1016\/j.biotechadv.2025.108694_bb0590","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1021\/acs.chemrev.7b00013","article-title":"Ligand-targeted drug delivery","volume":"117","author":"Srinivasarao","year":"2017","journal-title":"Chem. Rev."},{"issue":"9","key":"10.1016\/j.biotechadv.2025.108694_bb0595","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s40265-023-01891-8","article-title":"Rezafungin: First approval","volume":"83","author":"Syed","year":"2023","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.biotechadv.2025.108694_bb0600","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1016\/j.apsb.2022.09.022","article-title":"Harnessing the cyclization strategy for new drug discovery","volume":"12","author":"Tang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biotechadv.2025.108694_bb0605","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1038\/s41467-023-42437-6","article-title":"Circular single-stranded DNA as switchable vector for gene expression in mammalian cells","volume":"14","author":"Tang","year":"2023","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biotechadv.2025.108694_bb0610","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/bip.22669","article-title":"Cyclic peptides on a merry-go-round; towards drug design","volume":"104","author":"Tapeinou","year":"2015","journal-title":"Biopolymers"},{"issue":"5","key":"10.1016\/j.biotechadv.2025.108694_bb0615","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nprot.2007.152","article-title":"Split-intein mediated circular ligation used in the synthesis of cyclic peptide libraries in E. Coli","volume":"2","author":"Tavassoli","year":"2007","journal-title":"Nat. Protocols"},{"issue":"4","key":"10.1016\/j.biotechadv.2025.108694_bb0620","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1039\/D2MD00409G","article-title":"Computational design of a cyclic peptide that inhibits the ctla4 immune checkpoint","volume":"14","author":"Thakkar","year":"2023","journal-title":"RSC Med. Chem."},{"issue":"1","key":"10.1016\/j.biotechadv.2025.108694_bb0625","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ddtec.2011.07.005","article-title":"Discovery and applications of naturally occurring cyclic peptides","volume":"9","author":"Thorstholm","year":"2012","journal-title":"Drug Discov. Today Technol."},{"issue":"1","key":"10.1016\/j.biotechadv.2025.108694_bb0630","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1021\/acssynbio.2c00462","article-title":"Machine learning directed aptamer search from conserved primary sequences and secondary structures","volume":"12","author":"Tobia","year":"2023","journal-title":"ACS Syn. Biol."},{"issue":"3","key":"10.1016\/j.biotechadv.2025.108694_bb0635","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0968-0004(02)02057-1","article-title":"Circular proteins - no end in sight","volume":"27","author":"Trabi","year":"2002","journal-title":"Trend. Biochem. Sci."},{"key":"10.1016\/j.biotechadv.2025.108694_bb0640","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s10529-019-02689-z","article-title":"Spytag\/spycatcher cyclization enhances the thermostability and organic solvent tolerance of l-phenylalanine aldolase","volume":"41","author":"Wang","year":"2019","journal-title":"Biotechnol. Lett."},{"issue":"1","key":"10.1016\/j.biotechadv.2025.108694_bb0645","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.biotechadv.2025.108694_bb0650","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.667","article-title":"Circular RNA-based neoantigen vaccine for hepatocellular carcinoma immunotherapy","volume":"5","author":"Wang","year":"2024","journal-title":"Medcomm"},{"key":"10.1016\/j.biotechadv.2025.108694_bb0655","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijbiomac.2021.10.113","article-title":"Erythrocyte membrane-camouflaged gefitinib\/albumin nanoparticles for tumor imaging and targeted therapy against lung cancer","volume":"193","author":"Wen","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.biotechadv.2025.108694_bb0660","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acscentsci.8b00098","article-title":"Machine learning to predict cell-penetrating peptides for antisense delivery","volume":"4","author":"Wolfe","year":"2018","journal-title":"ACS Central Sci."},{"issue":"45","key":"10.1016\/j.biotechadv.2025.108694_bb0665","doi-asserted-by":"crossref","first-page":"2409893","DOI":"10.1002\/adma.202409893","article-title":"Activatable fluorescence and bio\/chemiluminescence probes for aminopeptidases: from design to biomedical applications","volume":"36","author":"Wu","year":"2024","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.biotechadv.2025.108694_bb0670","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1016\/j.biomaterials.2011.12.030","article-title":"Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging","volume":"33","author":"Xiao","year":"2012","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.biotechadv.2025.108694_bb0675","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1021\/jacs.2c12666","article-title":"Engineering a ligase binding DNA aptamer into a templating DNA scaffold to guide the selective synthesis of circular dnazymes and DNA aptamers","volume":"145","author":"Yan","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.biotechadv.2025.108694_bb0680","doi-asserted-by":"crossref","first-page":"9562","DOI":"10.1021\/acsnano.9b09884","article-title":"Circular bispecific aptamer-mediated artificial intercellular recognition for targeted t cell immunotherapy","volume":"14","author":"Yang","year":"2020","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biotechadv.2025.108694_bb0685","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41392-022-01176-8","article-title":"Extrachromosomal circular DNA: biogenesis, structure, functions and diseases","volume":"7","author":"Yang","year":"2022","journal-title":"Signal Transduct. Target.Ther."},{"issue":"8\u20139","key":"10.1016\/j.biotechadv.2025.108694_bb0690","article-title":"Recent advances in non-standard macrocyclic peptide ligand discovery using mRNA display","volume":"64","author":"Yin","year":"2024","journal-title":"Isr. J. Chem."},{"issue":"12","key":"10.1016\/j.biotechadv.2025.108694_bb0695","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.biotechadv.2025.108694_bb0700","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.febslet.2009.02.003","article-title":"The naturally split dnae intein exhibits an extraordinarily high rate in the protein-splicing reaction","volume":"583","author":"Zettler","year":"2009","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.biotechadv.2025.108694_bb0705","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1021\/mp100238j","article-title":"Loop 2 of toxin b binds with neuronal nicotinic acetylcholine receptors and enhances intracranial drug delivery","volume":"7","author":"Zhan","year":"2010","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.biotechadv.2025.108694_bb0710","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/ncomms3157","article-title":"Visualization of caspase-3-like activity in cells using a genetically encoded fluorescent biosensor activated by protein cleavage","volume":"4","author":"Zhang","year":"2013","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biotechadv.2025.108694_bb0715","doi-asserted-by":"crossref","first-page":"631","DOI":"10.31635\/ccschem.020.202000170","article-title":"Y-shaped circular aptamer\u2013dnazyme conjugates for highly efficient in vivo gene silencing","volume":"2","author":"Zhang","year":"2020","journal-title":"CCS Chem."},{"issue":"18","key":"10.1016\/j.biotechadv.2025.108694_bb0720","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024102118","article-title":"An intracellular nanobody targeting t4ss effector inhibits ehrlichia infection","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"25","key":"10.1016\/j.biotechadv.2025.108694_bb0725","doi-asserted-by":"crossref","first-page":"11279","DOI":"10.1039\/D1NR00836F","article-title":"Redirecting natural killer cells to potentiate adoptive immunotherapy in solid tumors through stabilized y-type bispecific aptamer","volume":"13","author":"Zheng","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.biotechadv.2025.108694_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105453","article-title":"A designed cyclic peptide based on trastuzumab used to construct peptide-drug conjugates for its her2-targeting ability","volume":"117","author":"Zhou","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biotechadv.2025.108694_bb0735","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cbpa.2017.02.006","article-title":"Cyclic peptide therapeutics: past, present and future","volume":"38","author":"Zorzi","year":"2017","journal-title":"Curr. Opin. Chem. Biol."}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975025001806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975025001806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:21:59Z","timestamp":1762309319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0734975025001806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":147,"alternative-id":["S0734975025001806"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2025.108694","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering cyclized biomolecules for advanced diagnostic and therapeutic applications","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotechadv.2025.108694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108694"}}